Chongqing Mas Sci&Tech (300275) fair value: what the stock is really worth
As of Nov 6, 2026: fair value (intrinsic value) of Chongqing Mas Sci&Tech stock ¥2.39, price ¥8.20, that is 70.9% below the price, quality 51 out of 100. Rating: strongly overvalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 3, 2026.
How to read this chart
60‑month range ¥5.03 – ¥18.92 · fair‑value band ¥1.81 – ¥3.47 · the ¥8.20 price screens above the ¥2.39 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 1 fiscal year is left out: there the valuation rested on only a fraction of the usual models. As of Nov 3, 2026.
Follow Chongqing Mas Sci&Tech in your weekly email
Every Wednesday you see whether Chongqing Mas Sci&Tech is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Chongqing Mas Sci.&Tech. Co.,Ltd. engages in the research, development, design, production, marketing, operation, and maintenance of technologies and equipment in the field of the Internet of Things and security in China.
Show moreShow less
It is also involved in mining, environmental protection, and city management businesses.
In addition, the company offers flammable gas monitoring products and environmental protection products comprising dust and noise, surface water, ambient air quality, VOCs, regional environment, and remote water operation products.
Further, it provides urban pipeline safety products consisting of a cloud data center, an information management platform, an emergency command system, and gas hazard monitoring products, as well as software solutions. The company was founded in 2003 and is headquartered in Chongqing, China.
Stock analysis
Chongqing Mas Sci&Tech (300275) currently trades at ¥8.20, while our model-based Fair Value estimate is ¥2.39, 71% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of ¥3.23 per share, and 1 of the 26 models we run sit above the ¥8.20 price.
Bear case: the Dividend Discount group reads lowest at ¥0.5750, and 25 of the 26 models stay below the price. Data coverage for this calculation is high.
Scenario range: ¥1.81 (bear) to ¥3.47 (bull), the price of ¥8.20 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 51/100 (solid quality), in the Industrials sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Chongqing Mas Sci&Tech reported revenue of 435M CNY in FY2025 versus 309M CNY in FY2021, a compound +8.9%/yr. Reported net income was 40.8M CNY in FY2025, compounding +8.7%/yr from FY2021.
Key figures
Market cap 2.5B CNY (≈ $378M) Small · P/E ratio 63.1 · P/S ratio 5.93 · EPS (TTM) ¥0.1300 · Dividend yield 0.4% · Net margin 9.0% · Return on equity 4.1% · Return on assets (EBIT) 4.4% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 39 out of 100 (low confidence).
What moves the price
The share trades about 43% below its 52-week high and 10% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Industrials peers we cover trades at 1% fair-value upside, at −71%, 300275 screens richer than that median.
Fair Value models
Bear¥1.81Fair Value ¥2.39Bull¥3.47
Price ¥8.20 · Downside -70.9%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (¥0.0815 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.72/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
−13.0%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+5.0%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+8.9%
Start year 2020 (pandemic). Over 10 years: +12.1% a year
Revenue growth 17 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+10.9%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
−3.1%
Earnings growth per share plus dividend.
Earnings per share, growth per year−3.5%
Dividend (yield on the price)0.4%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.17% → 16%
⚠ Revenue per share shrinking 2.0%/yr over ~6Y (margins intact) ⓘStructural-decline marker: revenue PER SHARE has fallen over the last decade (robust median trend, not a single year). Backtested across 2005 to 2017, such businesses trailed the market by about 2.5 percentage points per year. Display only: it does not change the fair value or the quality score.
Growth Forecast
A lot of optimism in the price
The price assumes more growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+35.5%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (China: IMF forecast 1.7% a year to 2030, 1.4% from 2016 to 2025) that is about +33.3% a year for the price.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Security & Protection Services · 105 stocks
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Chongqing Mas Sci&Tech Fair Value". https://www.fairvalue-calculator.com/stock/300275
Frequently asked questions
Is Chongqing Mas Sci&Tech (300275) overvalued or undervalued?
As of Nov 3, 2026, our model estimates a fair value of ¥2.39 versus a price of ¥8.20, about 71% lower (overvalued).
What is the fair value of 300275?
Our model-based fair value for Chongqing Mas Sci&Tech is ¥2.39 (as of Nov 3, 2026), built from audited fundamentals. The current price: ¥8.20.
What is the quality score of 300275?
Chongqing Mas Sci&Tech has a Quality Score of 51/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Chongqing Mas Sci&Tech (300275)?
Our model-based price target is the fair value of ¥2.39 (as of Nov 3, 2026) from 26 valuation models. Cautious scenario ¥1.81, optimistic scenario ¥3.47. It is a calculation from audited fundamentals, not an analyst target.
What is the Chongqing Mas Sci&Tech stock forecast for 2026?
Our models put fair value at ¥2.39, about 71% lower versus a price of ¥8.20 (overvalued). Cautious scenario ¥1.81, optimistic scenario ¥3.47. The calculation is refreshed regularly with new filings.
What is the revenue of Chongqing Mas Sci&Tech (300275)?
Chongqing Mas Sci&Tech reported trailing-twelve-month revenue of about 426M CNY (latest available figure, as of Nov 3, 2026).
Does Chongqing Mas Sci&Tech pay a dividend?
Chongqing Mas Sci&Tech currently shows a dividend yield of 0.43% relative to its recent price (as of Nov 3, 2026).
How much is the dividend of Chongqing Mas Sci&Tech (300275) and when is the ex-dividend date?
Chongqing Mas Sci&Tech pays a dividend of ¥0.035 per share a year, a dividend yield of 0.4%. The last ex-dividend date was May 28, 2026. A dividend has been paid every year since 2020. The payout ratio is 26.9% of earnings. Free cash flow covers the dividend 3.34 times. Our assessment: Well covered. A low payout and the dividend is fully funded by free cash flow, a comfortable, sustainable dividend.
What growth is priced into Chongqing Mas Sci&Tech (300275)?
For today's price to be fair in a discounted-cash-flow model, Chongqing Mas Sci&Tech would have to grow free cash flow by +35.5 % per year for five years (discount rate 10.4 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +8.9 % per year. As of Nov 3, 2026.
What discount rate (WACC) does the fair value of 300275 use?
Our models discount Chongqing Mas Sci&Tech at 10.4 %: a base by market capitalisation (small), damped by beta 0.38, country premium for China. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Chongqing Mas Sci&Tech that is +35.5 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (10.4 %) and the same formula as our fair value.
How much growth has Chongqing Mas Sci&Tech (300275) delivered so far?
Over the past 5 years revenue at Chongqing Mas Sci&Tech grew +8.9 % a year. The price currently implies free-cash-flow growth of +35.5 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Chongqing Mas Sci&Tech (300275) growing?
The median revenue growth in the sector is +7.8 % a year. That is the yardstick for the growth priced into Chongqing Mas Sci&Tech (+35.5 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Chongqing Mas Sci&Tech (300275)?
The free-cash-flow yield on the price is 1.43 %: that much free cash flow Chongqing Mas Sci&Tech produces per unit of market value. When it exceeds the discount rate of our models (10.4 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Chongqing Mas Sci&Tech (300275)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Chongqing Mas Sci&Tech it is ¥2.39 per share (as of Nov 3, 2026), against a price of ¥8.20. It is the blended result of 26 valuation models in 8 families (DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is Chongqing Mas Sci&Tech stock overvalued or undervalued in 2026?
As of Nov 3, 2026, 300275 trades above its calculated fair value: price ¥8.20, fair value ¥2.39, a gap of about −71% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 300275?
No. The price is what the market pays today (¥8.20); the fair value is what the company's own numbers justify (¥2.39). For Chongqing Mas Sci&Tech the two are ¥5.81 per share apart. That gap is exactly why we show both numbers side by side.
How much is Chongqing Mas Sci&Tech worth?
The market values Chongqing Mas Sci&Tech at about 2.5B CNY (market capitalisation, as of Nov 3, 2026). Per share that is ¥8.20; our models calculate a fair value of ¥2.39 per share.
What do the bullish and bearish scenarios say about 300275?
Our models span a range for Chongqing Mas Sci&Tech: cautious scenario ¥1.81, base ¥2.39, optimistic ¥3.47 per share (as of Nov 3, 2026, price ¥8.20). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 300275?
Chongqing Mas Sci&Tech trades at a price-to-earnings ratio of 63.1 (as of Nov 3, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ¥2.39 is built from several models across several years. Other multiples: P/B 2.7, P/S 5.9, EV/EBITDA 41.6.
How solid is the balance sheet of Chongqing Mas Sci&Tech (300275)?
Balance-sheet figures for Chongqing Mas Sci&Tech (as of Nov 3, 2026): return on equity 4.1%, debt of 0.03 per unit of equity. They feed the Quality Score of 51/100, which measures business quality independently of the share price.
How far is 300275 from its 52-week high?
Chongqing Mas Sci&Tech trades at ¥8.20, about 43% below its 52-week high of ¥14.47 and 10% above the low of ¥7.47 (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of ¥2.39 is for.
Which stocks are comparable to Chongqing Mas Sci&Tech?
From the same area (Industrials) we also value Allegion plc, ADT Inc, Zhejiang Dahua Technology Co, MSA Safety Incorporated, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Chongqing Mas Sci&Tech stock attractive at the current price?
The data as of Nov 3, 2026: price ¥8.20, calculated fair value ¥2.39 (−71%), Quality Score 51/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 300275 calculated?
We run Chongqing Mas Sci&Tech through 26 models from 8 families: DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of ¥2.39 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Chongqing Mas Sci&Tech itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Chongqing Mas Sci&Tech (300275)?
The closing price on Nov 6, 2026 was ¥8.20. Our model-based fair value is ¥2.39, about 71% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Chongqing Mas Sci&Tech right now?
The price sits above even our optimistic bull case (¥3.47). The favourable scenario is already priced in. Solid but not exceptional quality (51/100) and above fair value, neither a clear bargain nor a standout compounder. A fairly wide model range (¥1.81 to ¥3.47) leaves room in how you read the outcome.
Key figures of Chongqing Mas Sci&Tech
How large is the market capitalisation of Chongqing Mas Sci&Tech (300275)?
The market capitalisation of Chongqing Mas Sci&Tech is 2.5B CNY (≈ $378M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Chongqing Mas Sci&Tech (300275)?
The price-to-sales ratio of Chongqing Mas Sci&Tech is 5.93 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Chongqing Mas Sci&Tech (300275)?
Earnings per share at Chongqing Mas Sci&Tech are ¥0.1300 (price ÷ EPS = P/E 63.1). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Chongqing Mas Sci&Tech (300275)?
The dividend yield of Chongqing Mas Sci&Tech is 0.4% (payout 26.9%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Chongqing Mas Sci&Tech (300275)?
The net margin of Chongqing Mas Sci&Tech is 9.0% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Chongqing Mas Sci&Tech (300275)?
The return on equity (ROE) of Chongqing Mas Sci&Tech is 4.1% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Chongqing Mas Sci&Tech (300275)?
On an EBIT basis the return on assets of Chongqing Mas Sci&Tech is 4.4% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Chongqing Mas Sci&Tech (300275)?
The operating margin of Chongqing Mas Sci&Tech is 13.3% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast are earnings growing at Chongqing Mas Sci&Tech (300275)?
Earnings per share at Chongqing Mas Sci&Tech are growing −6.3% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Chongqing Mas Sci&Tech (300275) carry?
The net debt of Chongqing Mas Sci&Tech is 15.0M CNY (fiscal year 2024, ≈ 0.4 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Chongqing Mas Sci&Tech in the live analysis
One click puts Chongqing Mas Sci&Tech on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Broad data
Nov 3, 2026